Acorah Software Products - Accounts Production 16.5.460 false true 31 January 2024 1 February 2023 false 1 February 2024 31 January 2025 31 January 2025 13857099 Mr Alexander Etheridge iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 13857099 2024-01-31 13857099 2025-01-31 13857099 2024-02-01 2025-01-31 13857099 frs-core:ComputerEquipment 2024-02-01 2025-01-31 13857099 frs-core:ShareCapital 2025-01-31 13857099 frs-core:RetainedEarningsAccumulatedLosses 2025-01-31 13857099 frs-bus:PrivateLimitedCompanyLtd 2024-02-01 2025-01-31 13857099 frs-bus:AbridgedAccounts 2024-02-01 2025-01-31 13857099 frs-bus:SmallEntities 2024-02-01 2025-01-31 13857099 frs-bus:AuditExempt-NoAccountantsReport 2024-02-01 2025-01-31 13857099 frs-bus:SmallCompaniesRegimeForAccounts 2024-02-01 2025-01-31 13857099 frs-bus:Director1 2024-02-01 2025-01-31 13857099 frs-bus:Director1 2024-01-31 13857099 frs-bus:Director1 2025-01-31 13857099 frs-countries:EnglandWales 2024-02-01 2025-01-31 13857099 2023-01-31 13857099 2024-01-31 13857099 2023-02-01 2024-01-31 13857099 frs-core:ShareCapital 2024-01-31 13857099 frs-core:RetainedEarningsAccumulatedLosses 2024-01-31
Registered number: 13857099
Etheridge Clinical Research Ltd
Unaudited ABRIDGED Financial Statements
For The Year Ended 31 January 2025
Contents
Page
Abridged Balance Sheet 1—2
Notes to the Abridged Financial Statements 3—5
Page 1
Abridged Balance Sheet
Registered number: 13857099
2025 2024
Notes £ £ £ £
FIXED ASSETS
Tangible Assets 4 1,208 328
1,208 328
CURRENT ASSETS
Debtors 233,260 144,292
Cash at bank and in hand 62,511 23,843
295,771 168,135
Creditors: Amounts Falling Due Within One Year (139,625 ) (108,689 )
NET CURRENT ASSETS (LIABILITIES) 156,146 59,446
TOTAL ASSETS LESS CURRENT LIABILITIES 157,354 59,774
PROVISIONS FOR LIABILITIES
Deferred Taxation (303 ) (82 )
NET ASSETS 157,051 59,692
CAPITAL AND RESERVES
Called up share capital 5 4 2
Profit and Loss Account 157,047 59,690
SHAREHOLDERS' FUNDS 157,051 59,692
Page 1
Page 2
For the year ending 31 January 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
All of the company's members have consented to the preparation of an Abridged Profit and Loss Account and an Abridged Balance Sheet for the year end 31 January 2025 in accordance with section 444(2A) of the Companies Act 2006.
On behalf of the board
Mr Alexander Etheridge
Director
29 October 2025
The notes on pages 3 to 5 form part of these financial statements.
Page 2
Page 3
Notes to the Abridged Financial Statements
1. General Information
Etheridge Clinical Research Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 13857099 . The registered office is 22 Wolfberry Drive, Liverpool, L11 1JU.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Turnover
Turnover is measured at the fair value of the consideration received or receivable net of value added taxes. Turnover includes revenue earned from the rendering of services.
Rendering of services
Turnover from the rendering of services is recognised by reference to the time spent servicing the clients plus reimbursement of expenses incurred.
2.3. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Computer Equipment 25% per annum reducing balance basis
2.4. Foreign Currencies
Monetary assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate ruling on the date of the transaction. Exchange differences are taken into account in arriving at the operating profit.
2.5. Taxation
Corporation tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
...CONTINUED
Page 3
Page 4
2.5. Taxation - continued
Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.
Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and assets reflect the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities.
Current or deferred tax for the year is recognised in profit or loss, except when they related to items that are recognised in other comprehensive income or directly in equity, in which case, the current and deferred tax is also recognised in other comprehensive income or directly in equity respectively.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2024: 1)
1 1
4. Tangible Assets
Total
£
Cost
As at 1 February 2024 583
Additions 1,321
Disposals (446 )
As at 31 January 2025 1,458
Depreciation
As at 1 February 2024 255
Provided during the period 190
Disposals (195 )
As at 31 January 2025 250
Net Book Value
As at 31 January 2025 1,208
As at 1 February 2024 328
Page 4
Page 5
5. Share Capital
2025 2024
£ £
Allotted, Called up and fully paid 4 2
6. Directors Advances, Credits and Guarantees
Included within Debtors are the following loans to directors:
As at 1 February 2024 Amounts advanced Amounts repaid Amounts written off As at 31 January 2025
£ £ £ £ £
Mr Alexander Etheridge 90,632 197,098 149,916 - 137,814
The above loan is unsecured and repayable on demand. Interest of £3,947 has been charged at 2.25% on the overdrawn loan account.
Page 5